| Filed On | Filing |
|---|---|
| 29 Sep 2026 |
Form 4: Yan Andrew Y, Director
Sold 850 shares ($3.01K) |
| 28 Sep 2026 | 144 |
| 28 Sep 2026 |
Form 4: Yan Andrew Y, Director
Sold 330,000 shares ($2.48M) · Sold 326,700 shares ($2.4M) |
| 24 Sep 2026 | 144 |
| 21 Sep 2026 | FORM 6-K |
| 01 Sep 2026 |
Form 3: Lou Dong, Director
No securities owned |
| 25 Aug 2026 | FORM 6-K |
| 13 Aug 2026 | FORM 6-K |
| 10 Aug 2026 | SCHEDULE 13G/A |
| 30 Jun 2026 | FORM 6-K |
| 10 Jun 2026 |
Form 4: Chen Xiaohuan, Director
Bought 4,000 shares ($57.6K) |
| 03 Jun 2026 | FORM 6-K |
| 27 May 2026 | FORM 6-K |
| 22 May 2026 |
Form 4: Zuoli Xu, Director
Granted 55,212 Stock Option (right to buy) |
| 22 May 2026 |
Form 4: Yan Zheng, Chief Risk Officer
Granted 294,464 Stock Option (right to buy) |
| 22 May 2026 |
Form 4: Haisheng Wu, Director
Granted 658,462 Stock Option (right to buy) |
| 13 May 2026 | SCHEDULE 13G |
| 13 May 2026 | FORM 6-K |
| 12 May 2026 | FORM 6-K |
| 28 Apr 2026 | FORM 6-K |
Loading...
